New pill challenges chemo for Tough-to-Treat lung cancer
NCT ID NCT04447118
Summary
This study tested whether a daily pill called pyrotinib works better than standard chemotherapy (docetaxel) for people with advanced non-squamous lung cancer that has a specific HER2 gene mutation and has worsened after initial platinum-based chemotherapy. It involved 151 participants who were randomly assigned to receive either the new pill or the chemotherapy. The main goal was to see which treatment better delayed cancer growth and was safer for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SQUAMOUS NSCLC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AP-HM - Hôpital Nord
Marseille, France
-
ASST dei Sette Laghi-Ospedale di Circolo e Fondazione Macchi di Varese
Varese, Italy
-
Ajou University Hospital
Gyeonggi-do, South Korea
-
Ankara Sehir Hastanesi
Ankara, Turkey (Türkiye)
-
Antwerp University Hospital (UZA)
Edegem, Belgium
-
Arkhangelsk Clinical Oncological Dispensary
Arkhangelsk, Russia
-
Asan Medical Center
Seoul, South Korea
-
Azienda Ospedaliero Universitaria Policlinico G. Rodolico-San Marco - Presidio Ospedaliero G. Rodolico
Catania, Italy
-
Baskent University Adana Application and Research Center
Adana, Turkey (Türkiye)
-
Border Medical Oncology
Albury, Australia
-
CHRU Strasbourg
Strasbourg, France
-
CHU Toulouse - Hopital Larrey
Toulouse, France
-
Calvary North Adelaide Hospital
North Adelaide, Australia
-
Cangzhou Hospital of Integrated Tcm-Wm.Hebei
Cangzhou, Hebei, China
-
Centre Francois Baclesse
Caen, France
-
Centre Hospitalier Intercommunal Creteil
Créteil, France
-
Centro Riferimento Oncologico - Aviano
Aviano, Italy
-
Centrum Onkologii KOMED
Konin, Poland
-
China Medical University Hospital
Taichung, Taiwan
-
Clinical hospital RZD-Medicine of St. Petersburg
Saint Petersburg, Russia
-
Complejo Hospitalario de Navarra
Pamplona, Spain
-
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
New York, New York, 10021, United States
-
Eurocityclinic LLC
Saint Petersburg, Russia
-
First Affiliated Hospital of ZhengzhouUniversity
Zhengzhou, Henan, China
-
Florida Cancer Specialists North Divisio
St. Petersburg, Florida, 33701, United States
-
Florida Cancer Specialists South Divisio
Fort Myers, Florida, 33901, United States
-
Fudan University Cancer hospital
Shanghai, Shanghai Municipality, China
-
Gabrail Cancer Center
Canton, Ohio, 44718, United States
-
General Hospital of Tianjin Medical University
Tianjin, Tianjin Municipality, China
-
Gulhane Training and Research Hospital
Keçiören, Turkey (Türkiye)
-
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China
-
Henan Cancer Hospital
Zhengzhou, Henan, China
-
Hopital Bichat - Claude Bernard - AP-HP
Paris, France
-
Hospital Clinic Barcelona
Barcelona, Spain
-
Hospital Fundación Jiménez Díaz
Madrid, Spain
-
Hospital Germans Trias i Pujol
Barcelona, Badalona, Spain
-
Hospital Regional Universitario de Malaga
Málaga, Spain
-
Hospital Universitario 12 de Octubre
Madrid, Spain
-
Hospital Universitario Vall d'Hebron
Barcelona, Badalona, Spain
-
Hospital Universitario Virgen del Rocio
Seville, Spain
-
Hubei cancer hospital WardII
Wuhan, Hubei, China
-
Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University
Changsha, Hunan, China
-
Innovative Clinical Research Institute
Whittier, California, 33756, United States
-
Instituto Valenciano de Oncologia
Valencia, Spain
-
Instytut Genetyki i Immunologii GENIM
Lublin, Poland
-
Istanbul University Cerrahpasa Medical Faculty
Istanbul, Turkey (Türkiye)
-
Istituto Europeo di Oncologia
Milan, Italy
-
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori
Meldola (FC), Italy
-
Izmir Medical Park Hospital
Izmir, Turkey (Türkiye)
-
JSC Group of companies Medsi
Moscow, Russia
-
Jiangsu Cancer Hospital
Nanjing, Jiangsu, China
-
Jilin Cancer Hospital
Changchun, Jilin, China
-
Klinikverbund Kempten-Oberallgäu gGmbH
Kempten, Germany
-
Korea University Anam Hospital
Seoul, South Korea
-
Linkou Chang Gung Memorial Hospital (CGMHLK)
Taoyuan, Taiwan
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Med Polonia Sp. z o.o.
Poznan, Poland
-
Necmettin Erbakan University Selcuklu Faculty of Medicine
Konya, Turkey (Türkiye)
-
POIS Leipzig GbR
Leipzig, Germany
-
Peking university Cancer Hospital
Beijing, Beijing Municipality, China
-
Petrov National Medical Research Center of Oncology
Saint Petersburg, Sankt-Peterburg, Russia
-
Pius-Hospital Oldenburg, Centre of Radiotherapy and Medical Oncology, Dept. Medical Oncology
Oldenburg, Germany
-
Royal North Shore Hospital
St Leonards, Saint Leonards, Australia
-
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China
-
Saint-Petersburg Clinical Research Center of Specialized Types of Medical Care (Oncology)
Saint Petersburg, Russia
-
Salve-Medica
Lodz, Poland
-
Samsung Medical Center
Seoul, South Korea
-
Seoul National University Bundang Hospital
Seoul, Bundang, South Korea
-
Seoul St. Mary's Hospital, The Catholic University of Korea
Seoul, South Korea
-
Severance Hospital, Yonsei University Health System
Seoul, South Korea
-
Shandong Cancer Hospital Affiliated to Shandong University
Jinan, Shandong, China
-
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, China
-
Shanghai Pulmonary Hospital, Tongji University
Shanghai, Shanghai Municipality, 200433, China
-
Shanxi Provincial Cancer Hospital
Taiyuan, Shanxi, China
-
SiChuan Cancer Hospital
Chengdu, Sichuan, China
-
Sir Charles Gairdner Hospital
Nedlands, Australia
-
Sir Run Run Shaw Hospital ZheJiang University School Of Medicine
Hangzhou, Zhejiang, China
-
St Vincent's Hospital Melbourne
Fitzroy, Australia
-
Subei People's Hospital of Jiangsu Province
Yangzhou, Jiangsu, China
-
Summit Cancer Centers - North Spokane
Spokane, Washington, 99208, United States
-
Taipei Veterans General Hospital
Taipei, Taiwan
-
Taizhou Hospital of Zhejiang Province
Taizhou, Zhejiang, China
-
Tennessee Oncology
Nashville, Tennessee, 33756, United States
-
The First Affiliated Hospital of Guangdong Pharmaceutical University
Guangzhou, Guangdong, China
-
The First Affiliated Hospital,ZheJiang University
Hangzhou, Zhejiang, China
-
The Second Affiliated of Nanchang University
Nanchang, Jiangxi, China
-
The Second People's Hosipital of Yibin
Yibin, Sichuan, China
-
The affiliated hospital of inner mongolia medical univerity
Hohhot, Neimenggu, China
-
The second affiliated hospital of ChongQing medical university
Chongqing, Chongqing Municipality, China
-
Trakya University Medical Faculty
Center, Turkey (Türkiye)
-
Uniklinikum Giessen und Marburg
Giessen, Germany
-
Universitaetsklinikum Carl Gustav Carus Dresden
Dresden, Germany
-
University Hospital (UZ) Leuven
Leuven, Belgium
-
University Hospital Gent
Ghent, Belgium
-
University of California (UC) Davis Comprehensive Cancer Center
Sacramento, California, 95817, United States
-
University of California - Irvine Medical Center
Orange, California, 92868, United States
-
University of Kansas Medical Center (KUMC)
Kansas City, Kansas, 66160, United States
-
West China Hospital,Sichuan University
Chengdu, Sichuan, China
-
Yunnan Provincial Cancer Hospital
Kunming, Yunnan, China
-
ZheJiang Cancer Hospital
Hangzhou, Zhejiang, China
-
beijing chest hospital,Capital medical university
Beijing, Beijing Municipality, China
-
the Second Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
Conditions
Explore the condition pages connected to this study.